RxDoctor Payments DataLook up a doctor →

Parag Patel, MD

Family Medicine · Hammonton, NJNPI 1689751646

Payments from drug & device makers

$24,169in general payments, 2019–2025

Across 1,552 payments — averaging $15.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • AbbVie$2K
  • Novo Nordisk$2K
  • Pfizer$1K
  • Amgen$1K
  • GSK$1K
  • plus $13K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca130$2,571
AbbVie(2 entities)174$2,278
Novo Nordisk178$2,222
Pfizer126$1,472
Amgen(2 entities)84$1,326
GSK90$1,299
Boston Scientific18$913
Boehringer Ingelheim66$869
Otsuka America Pharmaceutical, Inc.46$850
Lilly USA, LLC55$778
Abbott22$634
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC49$617
Antares Pharma, Inc.18$585
Amarin Pharma, Inc.53$556
Merck37$499
Biohaven Pharmaceutical Holding Company Ltd.22$473
Teva Pharmaceuticals USA, Inc.26$375
Daiichi Sankyo Inc.20$327
Johnson & Johnson22$312
Lundbeck LLC19$298
Abiomed7$283
Kowa Pharmaceuticals America, Inc.20$266
Eisai Inc.17$241
Novartis16$240
Takeda Pharmaceuticals U.S.A., Inc.19$233
Bayer13$227
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$205
Phathom Pharmaceuticals, Inc.12$192
IBSA Pharma Inc.11$175
Dexcom, Inc.9$154
Alkermes, Inc.10$146
Biohaven Pharmaceuticals, Inc.10$138
Astellas Pharma US Inc9$134
Exact Sciences7$121
Sanofi-aventis U.S. LLC8$120
Axsome Therapeutics, Inc.7$117
Dova Pharmaceuticals1$117
Idorsia Pharmaceuticals US Inc8$116
ZOLL Circulation Inc1$113
Vanda Pharmaceuticals Inc.6$110
Comsort, Inc1$100
Corium, LLC6$96
Jazz Pharmaceuticals Inc.7$94
Adlon Therapeutics L.p.7$91
Almatica Pharma LLC5$73
Collegium Pharmaceutical, Inc.5$71
Currax Pharmaceuticals LLC5$67
Halozyme Inc4$64
Harmony Biosciences LLC4$61
E.r. Squibb & Sons, L.L.C.4$48
Esperion Therapeutics, Inc.3$43
Kaleo, Inc.3$41
Scilex Pharmaceuticals Inc.3$41
Bausch Health US, LLC3$40
Vivus LLC3$38
Clarus Therapeutics Inc.3$35
Nevro Corp.2$32
Corcept Therapeutics2$31
Neos Therapeutics, LP2$30
Xeris Pharmaceuticals, Inc.2$30

How this compares

$24,169 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.

See all family medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$262,272
Medicare patients
533
Services billed
4,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Hammonton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →